Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
With a market cap of 2.95B, Catalyst Pharmaceuticals(CPRX) trades at $24.01. The stock has a price-to-earnings ratio of 14.12.
On 2025-12-17, Catalyst Pharmaceuticals(CPRX) stock moved within a range of $23.88 to $24.45. With shares now at $24.01, the stock is trading +0.5% above its intraday low and -1.8% below the session's peak.
Trading volume for Catalyst Pharmaceuticals(CPRX) stock has reached 1.43M, versus its average volume of 1.44M.
The stock's 52-week range extends from a low of $19.05 to a high of $26.58.
The stock's 52-week range extends from a low of $19.05 to a high of $26.58.
CPRX News
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare...
